Trials / Completed
CompletedNCT05536115
Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket
Prospective, Multicentre Clinical Trial Measuring the Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Septodont · Industry
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
Alveogyl (Septodont, Saint-Maur-des-Fossés - France) is a Medical Device used as dressing in case of dry socket. ALVE study is a clinical investigation measuring Alveogyl performance and safety in patients with post-extraction dry socket. The study takes place in India and in France where Alveogyl is already marketed, since 2010 in France and since 2014 in India .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Alveogyl | The patients will be treated by Alveogyl. Global treatment protocol (curettage, cleaning, local anaesthesia etc.) of the dry socket is at the discretion of the Investigator. Alveogyl is used as an alveolar dressing. Placement of Alveogyl (about 0.2 g of paste) into the dental socket is done according to its instruction for use by a dental professional only. |
Timeline
- Start date
- 2022-12-13
- Primary completion
- 2025-06-26
- Completion
- 2025-06-26
- First posted
- 2022-09-10
- Last updated
- 2026-03-02
- Results posted
- 2026-02-09
Locations
16 sites across 2 countries: France, India
Source: ClinicalTrials.gov record NCT05536115. Inclusion in this directory is not an endorsement.